Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis

Published:2024-02 Issue: Volume:94 Page:102203
ISSN:1568-1637
Container-title:Ageing Research Reviews
language:en
Short-container-title:Ageing Research Reviews

Author:

Terao Itsuki^ORCID,Kodama Wakako

Publisher

Elsevier BV

Reference43 articles.

1. Brain volume loss due to donanemab;Ayton;Eur. J. Neurol.,2021

2. Two randomized phase 3 studies of Aducanumab in early Alzheimer's disease;Budd Haeberlein;J. Prev. Alzheimers Dis.,2022

3. Tau-targeting therapies for Alzheimer disease: current status and future directions;Congdon;Nat. Rev. Neurol.,2023

4. Revisiting global cognitive and functional state 13 years after a clinical trial of lithium for mild cognitive impairment;Damiano;Rev. Bras. De. Psiquiatr.,2023

5. GetReal in network meta-analysis: a review of the methodology;Efthimiou;Res Synth. Methods,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of imidazolylacetophenone oxime derivatives as novel brain-penetrant agents for Alzheimer's disease treatment;European Journal of Medicinal Chemistry;2024-11

2. Memantine administration enhances glutamatergic and GABAergic pathways in human hippocampus of Alzheimer´s disease patients;2024-08-05

3. Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs;Frontiers in Pharmacology;2024-07-11

4. Synthesis and Enzymatic Evaluation of a Small Library of Substituted Phenylsulfonamido-Alkyl Sulfamates towards Carbonic Anhydrase II;Molecules;2024-06-25

5. Lithium and its effects: does dose matter?;International Journal of Bipolar Disorders;2024-06-24